| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5950610 | Atherosclerosis | 2010 | 7 Pages |
Abstract
Our review suggests that some patients are susceptible to statin myopathy because of pre-existing subclinical inherited muscular disorders, or genetic variation in statin uptake proteins encoded by SLCO1B1 or the cytochrome P enzyme system. Variations in genes affecting pain perception and polymorphism in vascular receptors may also contribute to statin myopathy. None of the variants identified in this review suggested novel metabolic mechanisms leading to statin myopathy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Abhijit Ghatak, Osman Faheem, Paul D. Thompson,